|

ATM Kinase Inhibitor AZD1390 Clinical Trials

1 actively recruiting trial across 1 location

Also known as: AZD-1390, AZD1390

Pipeline

Phase 1: 1

Top Sponsors

  • Children's Oncology Group1

Indications

  • Childhood Malignant Glioma1
  • Childhood Glioblastoma1
  • Childhood Diffuse Midline Glioma1
  • Childhood Diffuse Intrinsic Pontine Glioma1
  • Childhood Astrocytoma1

Birmingham, Alabama1 trial

Testing the Addition of an Anti-Cancer Drug, AZD1390, During Radiation Therapy for Newly Diagnosed High Grade Glioma, Diffuse Midline Glioma, or Diffuse Intrinsic Pontine Glioma

Children's Hospital of Alabama

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.